Stocks
Haemonetics Corporation (HAE) EBITDA margin US GAAP (year values) |
|||||||||
| 2023 | 2024 | 2024 | 2025 | 2026 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 21.6% | 22.6% | 26.2% | 29.8% | 29.8% | |||
| Changes by years, y/y, % | +0pp | -22pp | +4pp | +4pp | +7.0% | ||||
Haemonetics Corporation. EBITDA margin, %
Haemonetics Corporation. EBITDA margin, changes, pp
Haemonetics Corporation (HAE) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | 2026Q4 | LTM ? | |||
| EBITDA margin, % | ? | 30.1% | 29.2% | 26.5% | 28.2% | 35.0% | 29.8% | |
| Changes by years, y/y, % | +10pp | +5pp | +1pp | +1pp | +5pp | |||
| Changes by quarters, q/q, % | +3pp | -1pp | -3pp | +2pp | +7pp | |||
